Quick Answer
QIAGEN N.V. reported Operating Income of $465.85 million for fiscal year 2025.
QIAGEN N.V. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $465.85M | +376.8% |
| 2024 | $97.71M | -76.2% |
| 2023 | $409.94M | -22.9% |
| 2022 | $531.46M | -15.7% |
| 2021 | $630.08M | +63.1% |
| 2020 | $386.43M | +1578.5% |
| 2019 | -$26.14M | -109.8% |
| 2018 | $266.58M | +73.8% |
| 2017 | $153.42M | +55.2% |
| 2016 | $98.83M | -44.9% |
| 2015 | $179.50M | +11.0% |
| 2014 | $161.69M | +155.3% |
| 2013 | $63.33M | -62.7% |
| 2012 | $169.81M | +70.5% |
| 2011 | $99.59M | -47.2% |
| 2010 | $188.54M | +4.6% |
| 2009 | $180.21M | +23.7% |
| 2008 | $145.66M | — |
- QIAGEN N.V. showed an increase of +376.8% in Operating Income compared to the prior fiscal year.
- Over the 2008–2025 period, QIAGEN N.V.’s operating income has grown by 219.8% (from $145.66 million to $465.85 million).
- The most recent figure is from QIAGEN N.V.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: